Computed tomography (CT) guided percutaneous biopsy is a frequently performed procedure to establish a pathologic diagnosis in thoracic disease. While the most frequent complication of percutaneous chest biopsy is pneumothorax, hemothorax is a rare but potentially fatal complication. The purpose of this study is to assess the risk of post biopsy hemothorax, its associated consequences, and describe reasonable precautions for minimizing this risk. A retrospective chart review of all percutaneous thoracic biopsies completed at two affiliated institutions from January 1, 2006 to June 30, 2011 was performed to evaluate complications rates. A total of 830 biopsies were performed over a five and a half year period. The overall complication rate was 34.1%, with the majority being pneumothorax (32.5%). A total of 4 confirmed hemothoraces (0.5%) occurred. The onset of hemothorax was variable with three cases occurring immediately post-procedure while a fourth occurred 15 hours later. Treatments included observation, tube thoracostomy, and thoracotomy. In conclusion, hemothorax is a rare but serious complication of percutaneous biopsy which may be more common than previously reported.
No takes yet. Share an insight, caveat, or question.
Weinberg et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: